General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Getinge, Inc.(MODEST), Zoll, Inc.(MODEST) RESEARCH/RESEARCH GRANTS: Amgen(NONE) OTHER FINANCIAL BENEFIT: Zoll(MODEST), Arrowhead Pharmaceuticals(NONE)

View Full Disclosure